Log in

Relevant bibliographies by topics / Endometroide / Journal articles

To see the other types of publications on this topic, follow the link: Endometroide.

Journal articles on the topic 'Endometroide'

Author: Grafiati

Published: 4 June 2021

Last updated: 10 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Endometroide.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Zivanovic, Aleksandar, Aleksandra Dimitrijevic, Tatjana Kastratovic, Janko Djuric, Vesna Stankovic, and Irena Tanaskovic. "Ovarian endometroid adenocarcinoma in pregnancy." Vojnosanitetski pregled 68, no. 2 (2011): 181–84. http://dx.doi.org/10.2298/vsp1102181z.

Full text

Abstract:

Background. Ovarian cancer is very rare in pregnancy. It is mainly of epithelial origin, low grade and low malignant potential. Case report. We presented a patient in which ultrasound confirmed the presence of clearly limited tumor in the left ovary when she was eight weeks pregnant. The results of 4D Color Doppler showed a central type of tumor vascularisation with resistance index (IR) less than 0.5. The Consultancy Board in Gynecology of the Institute for Oncology and Radiology of Serbia decided to remove the patient's left adnexa and intensively monitor the pregnancy period. The operation

APA, Harvard, Vancouver, ISO, and other styles

2

Purandare, Nikhil C., Gillian Ryan, Fathl Ramli, Kara Purcell, Andrew Curtain, and Morgan McCourt. "Endometroid Adenocarcinoma: A Possibility after Hysterectomy." Journal of South Asian Federation of Obstetrics and Gynaecology 2, no. 3 (2010): 230–32. http://dx.doi.org/10.5005/jp-journals-10006-1108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Beresford-Cleary, N., S. Mehdi, and B. Magowan. "Femoral metastases from ovarian serous/endometroid adenocarcinoma." Journal of Surgical Case Reports 2012, no. 7 (2012): 9. http://dx.doi.org/10.1093/jscr/2012.7.9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mahantshetty, Umesh, Aditi Aggarwal, Balasubramanium Ganesh, et al. "Clinical Outcome of Early-Stage Endometroid Adenocarcinoma." International Journal of Gynecological Cancer 23, no. 8 (2013): 1446–52. http://dx.doi.org/10.1097/igc.0b013e3182a2ff46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jain, Vanita, Sudesh Prabhakar, Rashmi Bagga, Jaswinder Kalra, and Sarala Gopalan. "Paraneoplastic cerebellar degeneration with ovarian endometroid carcinoma." Acta Obstetricia et Gynecologica Scandinavica 82, no. 7 (2003): 672–73. http://dx.doi.org/10.1034/j.1600-0412.2003.00169.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sansom, H. E., C. Fisher, and D. M. King. "Isolated bone metastasis from an endometroid ovarian carcinoma." Clinical Radiology 54, no. 2 (1999): 135–37. http://dx.doi.org/10.1016/s0009-9260(99)91076-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bigsby, Glenn E., Robert W. Holloway, Burkhard Weppelman, Robert B. Reynolds, and Briana Williams. "Endometroid adenocarcinoma of the uterus with cardiac metastasis." Gynecologic Oncology 97, no. 1 (2005): 256–59. http://dx.doi.org/10.1016/j.ygyno.2004.12.052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hocker, Nathaniel, Maria Story, Alysa Lerud, and Sarat Kuppachi. "Severe hypercalcaemia from ectopic intact parathyroid hormone secretion treated with continuous renal replacement therapy in a patient with two malignancies." BMJ Case Reports 14, no. 6 (2021): e242172. http://dx.doi.org/10.1136/bcr-2021-242172.

Full text

Abstract:

We present a 61-year-old Caucasian woman with endometroid carcinoma as well as a poorly differentiated adenocarcinoma who developed severe hypercalcaemia in the setting of an elevated intact parathyroid hormone. The patient was hospitalised twice for her condition. During her first hospitalisation, she was diagnosed with an endometroid carcinoma and hypercalcaemia. With medical management, she had a normal calcium level on discharge. She presented 3 weeks later with hypercalcaemia and encephalopathy. This time her hypercalcaemia was refractory to medical management, and required continuous ren

APA, Harvard, Vancouver, ISO, and other styles

9

HAYAKAWA, Seiichirou, Shinji SATO, Tadao TAKANO, et al. "A case of endometroid stromal sarcoma of the ovary." Journal of the Japanese Society of Clinical Cytology 34, no. 6 (1995): 1200–1204. http://dx.doi.org/10.5795/jjscc.34.1200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Purandare, N., F. Ramli, K. Purcell, M. McCourt, and A. Curtain. "P1084 Endometroid adenocarcinoma in a known case of endometriosis." International Journal of Gynecology & Obstetrics 107 (October 2009): S715. http://dx.doi.org/10.1016/s0020-7292(09)62569-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Peer, Michaela, Wolfgang Fellner, Beata E. Seeber, Alain G. Zeimet, and Christian Marth. "Endometroid carcinoma developing in endometriosis over the symphysis pubis." Gynecologic Oncology Case Reports 6 (November 2013): 45–46. http://dx.doi.org/10.1016/j.gynor.2013.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Agrawal, Priti, Rishi Agrawal, Jaswant Jain, and Anandi Lobo. "Postmenopausal endometrial carcinoma presenting as urinary incontinence: a case report." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 6 (2021): 2544. http://dx.doi.org/10.18203/2320-1770.ijrcog20212215.

Full text

Abstract:

Endometrial carcinoma (EC) most commonly presents with postmenopausal bleeding (PMB) or blood tinged vaginal discharge. Watery vaginal discharge is usually reported in fallopian tube malignancy. We reported a case of EC where she had profuse watery discharge from private part mimicking urine and so patient visited urologist for urinary incontinence and was later diagnosed as endometroid adenocarcinoma. A 73 year old female presented with history of passing urine involuntarily for last 3 months. Endometrial biopsy revealed endometrial endometroid adenocarcinoma-FIGO grade-2. FDG PET-CT scan rev

APA, Harvard, Vancouver, ISO, and other styles

13

Potapova, L. V., V. I. Grishchenko, and N. A. Shcherbina. "Character of local metabolic changes in foci of endometroid heterotopies." International Journal of Gynecology & Obstetrics 70 (2000): C90. http://dx.doi.org/10.1016/s0020-7292(00)80616-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Nassie, D. I., E. Yeoshoua, O. Raban, et al. "The Accuracy of Histology from Hysteroscopy in Endometroid Type Uterine Malignancies." Journal of Minimally Invasive Gynecology 25, no. 7 (2018): S122—S123. http://dx.doi.org/10.1016/j.jmig.2018.09.355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Abuzoda, U., and J. Preston. "A case of bilateral primary endometroid adenocarcinoma of the fallopian tubes." Journal of Obstetrics and Gynaecology 22, no. 5 (2002): 571–72. http://dx.doi.org/10.1080/014436102760299006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

'OLAFSDOTTIR, R., and PAUL KITCHING. "Cytological changes associated with tubo-endometroid metaplasia of the uterine cervix." Cytopathology 6, no. 2 (1995): 128. http://dx.doi.org/10.1111/j.1365-2303.1995.tb00460.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Palit, A., H. McDowell, H. Carty, R. Rintala, and G. Kokai. "Endometroid adenocarcinoma of the cervix in a 9-year-old girl." British Journal of Radiology 71, no. 850 (1998): 1093–95. http://dx.doi.org/10.1259/bjr.71.850.10211073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Rajani, M., G. Sailabala, C. Padmavathi devi, and M. Koteswari. "Ciliated cell variant of endometroid carcinoma in bilateral ovaries: A rare variant." IOSR Journal of Dental and Medical Sciences 13, no. 4 (2014): 07–09. http://dx.doi.org/10.9790/0853-13430709.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

KHATİB, Ghanim, Mehmet Ali VARDAR, Ahmet Baris GÜZEL, et al. "Obez endometroid endometrial kanserli olgulara pelvik lenfadenektomiye paraaortik lenfadenektomi eklenmesinin sağkalıma etkisi." Cukurova Medical Journal 45, no. 1 (2020): 134–40. http://dx.doi.org/10.17826/cumj.631216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Gogorza, S. J., A. Saavedra Sanchez, and R. Testa. "Complete resection of endometroid cysts: the Hospital Italiano from Buenos Aires experience." Fertility and Sterility 77 (February 2002): S54. http://dx.doi.org/10.1016/s0015-0282(01)03193-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Moberg, E., E. Hjerpe, R. J. Ehrsson, C. Möller, and B. Angelin. "Is endometroid cancer of the ovaries a late manifestation of Alström syndrome?" Journal of Internal Medicine 265, no. 2 (2009): 296–98. http://dx.doi.org/10.1111/j.1365-2796.2008.02003.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Anandita, Dr, Dr Indu R. Nair, and Dr Anupama Rajanbabu. "Synchronous type ii endometroid adenocarcinoma of the ovary and endometrium: A case report." International Journal of Clinical Obstetrics and Gynaecology 4, no. 5 (2020): 96–98. http://dx.doi.org/10.33545/gynae.2020.v4.i5b.689.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Mokhtar, N. M., F. SA Saghir, A. Mohd Dali, I. Mohamed Rose, and A. A. Jamal. "409. Differentially expressed genes in endometroid endometrial carcinoma using microarray: a preliminary report." Reproduction, Fertility and Development 20, no. 9 (2008): 89. http://dx.doi.org/10.1071/srb08abs409.

Full text

Abstract:

Background: Endometrial cancer is the commonest cancer among women in the western countries. It ranks the fourth in gynaecological cancers incidence in Malaysia. Endometriod carcinoma is the commonest subtype of endometrial cancer. The aetiology of this disease is still not fully understood. Previous theories have suggested the disease is caused by the activation of oncogenes and inactivation of the tumour suppressor genes. The aim of this study is to identify expressing genes involved in the endometrial carcinoma compared with the normal endometrium. Materials and Methods: All endometrial tis

APA, Harvard, Vancouver, ISO, and other styles

24

Alter, Raanan, William Adams, Alec Block, William Small, and Matthew M. Harkenrider. "Analysis of adjuvant chemotherapy and radiotherapy for stage II endometroid type endometrial cancer." Journal of Clinical Oncology 35, no. 15_suppl (2017): e17118-e17118. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e17118.

Full text

Abstract:

e17118 Background: Endometrial cancer (EC) is the most common gynecologic malignancy. Stage II EC - involving the cervix - is ideally treated with primary surgical staging; however, adjuvant treatment is not well defined. Methods: The population included 8,506 patients with 2009 FIGO Stage II endometrioid-type EC treated surgically within the National Cancer Database. Patients were categorized into six treatment groups: 1. hysterectomy (HYS) alone; 2. HYS with external beam radiation therapy (EBRT); 3. HYS with chemotherapy (CT); 4. HYS with CT and EBRT; 5. HYS with vaginal brachytherapy (VBT)

APA, Harvard, Vancouver, ISO, and other styles

25

Pun, Chin Bahadur, Sadina Shrestha, Ranjan Raj Bhatta, et al. "An Overview of Ovarian Tumours at B.P. Koirala Memorial Cancer Hospital, Nepal." Nepalese Journal of Cancer 3, no. 1 (2019): 44–48. http://dx.doi.org/10.3126/njc.v3i1.25915.

Full text

Abstract:

Introduction: Ovarian cancer is the seventh most commonly diagnosed cancer among women in the world. This study was conducted with the aim to find out different histological types of ovarian tumours reported at B.P. Koirala Memorial Cancer Hospital (BPKMCH), Chitwan, Nepal. Methods: This was a retrospective study carried out at the Department of Pathology of BPKMCH from January 1, 2018 to December 31, 2018. This study included the patients who were operated at BPKMCH or referred cases from elsewhere, but the specimen was processed and reported at BPKMCH. All the data were retrieved and a

APA, Harvard, Vancouver, ISO, and other styles

26

Vangoitsenhoven, M., and T. Van den Bosch. "EP26.08: Endometroid carcinoma not to be mistaken for deep infiltrating endometriosis on transvaginal ultrasound." Ultrasound in Obstetrics & Gynecology 50 (September 2017): 383. http://dx.doi.org/10.1002/uog.18751.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Dvorakova, Eva, Marcela Chmelarova, Jan Laco, Vladimir Palicka, and Jiri Spacek. "Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA." Biomedical Papers 157, no. 4 (2013): 298–303. http://dx.doi.org/10.5507/bp.2013.035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Zhong, Hui, Huiyu Chen, Huahong Qiu, Chen Huang, and Zhihui Wu. "A multiomics comparison between endometrial cancer and serous ovarian cancer." PeerJ 8 (January 9, 2019): e8347. http://dx.doi.org/10.7717/peerj.8347.

Full text

Abstract:

Background Endometrial carcinoma (EC) and serous ovarian carcinoma (OvCa) are both among the common cancer types in women. EC can be divided into two subtypes, endometroid EC and serous-like EC, with distinct histological characterizations and molecular phenotypes. There is an increasing awareness that serous-like EC resembles serous OvCa in genetic landscape, but a clear relationship between them is still lacking. Methods Here, we took advantage of the large-scale molecular profiling of The Cancer Genome Atlas(TCGA) to compare the two EC subtypes and serous OvCa. We used bioinformatics data a

APA, Harvard, Vancouver, ISO, and other styles

29

Costa, L. D., M. C. Dias, M. A. Alvarenga та J. L. Sequeira. "Identificação dos colágenos I, III, IV e α-SMA e participação dos miofibroblastos no processo fibrótico das endometroses equinas". Arquivo Brasileiro de Medicina Veterinária e Zootecnia 69, № 6 (2017): 1398–406. http://dx.doi.org/10.1590/1678-4162-9273.

Full text

Abstract:

RESUMO A endometrose é uma alteração degenerativa das glândulas uterinas e do estroma circundante, caracterizada pelo arranjo periglandular de miofibroblastos e pela deposição de matriz extracelular (ECM). O presente trabalho objetivou avaliar a expressão de colágenos tipos I, III e IV e α-actina de músculo liso (α-SMA) nas endometroses equinas, procurando esclarecer a participação dos miofibroblastos na progressão desses processos. Foram utilizadas 24 biópsias uterinas com diagnóstico de endometrose, recebidas pelo Serviço de Patologia Veterinária e de Reprodução Animal da FMVZ, Unesp, Botuca

APA, Harvard, Vancouver, ISO, and other styles

30

Rico, Sebastian Dwertmann, Frank Jacobsen, Christian Bernreuther, et al. "MUC5AC expression is linked to mucinous/endometroid subtype and absence of nodal metastasis in ovarian cancer." Pathology 53 (July 2021): S43—S44. http://dx.doi.org/10.1016/j.pathol.2021.06.088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kato, K., K. Suzuka, T. Osaki, M. Itami, and N. Tanaka. "Primary hepatoid adenocarcinoma of the uterine cervix." International Journal of Gynecologic Cancer 17, no. 5 (2007): 1150–54. http://dx.doi.org/10.1111/j.1525-1438.2007.00901.x.

Full text

Abstract:

Hepatoid adenocarcinoma is characterized histologically by neoplastic epithelial cells that resemble hepatocellular carcinoma (HCC) and produce alpha-fetoprotein (AFP). We describe a case of hepatoid adenocarcinoma of the uterus that, unlike any other previously reported case, was strictly confined to the cervix. A cervical biopsy demonstrated poorly differentiated adenocarcinoma, and hysterectomy and bilateral salpingo-oophorectomy were subsequently performed. Histologically, the lesion consisted of solid sheets of hepatoid cells accompanied with areas of endometroid adenocarcinoma. The tumor

APA, Harvard, Vancouver, ISO, and other styles

32

Lara, Ernesto. "Neoplasia intraepitelial endometrial: una lesión precursora de cáncer de endometrio." Revista de Obstetricia y Ginecología de Venezuela 81, no. 01 (2021): 75–85. http://dx.doi.org/10.51288/00810111.

Full text

Abstract:

Endometrial cancer represents worldwide the sixth most common malignant pathology in the female population, the endometroid type constitutes the most common form, usually developed from a typical sequence of endometrial hyperplasia secondary to sustained exposure to unopposed estrogens balanced by progestogens. Different classification systems for endometrial hyperplasia have been described, the most recent, published by the World Health Organization in 2014, proposes two categories: 1) hyperplasia without atypia, and 2) atypical hyperplasia or endometrial intraepithelial neoplasia. This class

APA, Harvard, Vancouver, ISO, and other styles

33

Khairy, DinaA, and AblaS Mahmoud. "CLINICOPATHOLOGICAL SIGNIFICANCES OF STEM CELL MARKERS SOX-2& PIWIL1 EXPRESSIONS IN ENDOMETROID CARCINOMA OF THE UTERUS." International Journal of Advanced Research 5, no. 6 (2017): 1025–37. http://dx.doi.org/10.21474/ijar01/4505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Dessources, K., A. D. C. Paula, P. Cybulska, et al. "Whole-exome sequencing and clonal evolution of brain metastases in low-grade early-stage endometroid endometrial adenocarcinoma." Gynecologic Oncology 159 (October 2020): 222–23. http://dx.doi.org/10.1016/j.ygyno.2020.05.369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Singh, N., R. Tripathi, Y. M. Mala, N. Khurana, and M. Khan. "Large functional benign endometroid cystadenofibroma of the ovary leading to endometrial cystic glandular hyperplasia and postmenopausal bleeding." Case Reports 2013, jun11 1 (2013): bcr2013010323. http://dx.doi.org/10.1136/bcr-2013-010323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Wang, Bo, Qian Wang, Yue Shi, et al. "Clinical features related to lymphatic metastasis in grade 3 endometroid endometrial cancer: a retrospective cross-sectional study." Chinese Medical Journal 134, no. 17 (2021): 2102–9. http://dx.doi.org/10.1097/cm9.0000000000001749.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

De Soto, Joseph. "The Treatment of Clear Cell Ovarian Cancer with the Poly(ADP- Ribose) Polymerase (PARP1) Inhibitors (AG14361,Veliparib,Olaparib) as Chemosensitizers." Journal of Current Medical Research and Opinion 3, no. 11 (2020): 732–38. http://dx.doi.org/10.15520/jcmro.v3i11.362.

Full text

Abstract:

Introduction: Most of those who get ovarian cancer will die from this cancer. Of the major types of ovarian cancer clear cell carcinoma is the most aggressive and chemoresistant type of epithelial ovarian cancer. Here the sensitivity of clear cell ovarian carcinoma to poly adenosine diphosphate [ADP-ribose] polymerase (PARP) inhibitors is tested. Methodology: Ovarian cancer cell lines were treated with the PARP inhibitors AG14361, Veliparib, or Olaparib alone or in combination with cisplatin, carboplatinum, doxorubicin, 5-fluorouracil (5-FU), gemcitabine and paclitaxel for 72 hours. The IC50 c

APA, Harvard, Vancouver, ISO, and other styles

38

Shafiee, Mohamad Nasir, Lim Pei Shan, Shuhaila Ahmad, Nazimah Idris, and Mohd Hashim Omar. "The use of gonadotrophin-releasing hormone (GnRH) analogue in endometroid adenocarcinoma of the ovary: a case report and discussion." European Journal of Obstetrics & Gynecology and Reproductive Biology 161, no. 1 (2012): 110–11. http://dx.doi.org/10.1016/j.ejogrb.2011.11.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

George, Lisanne, Amy Winship, Kelli Sorby, Evdokia Dimitriadis, and Ellen Menkhorst. "Profilin-1 is dysregulated in endometroid (type I) endometrial cancer promoting cell proliferation and inhibiting pro-inflammatory cytokine production." Biochemical and Biophysical Research Communications 531, no. 4 (2020): 459–64. http://dx.doi.org/10.1016/j.bbrc.2020.07.123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Rico, Sebastian Dwertmann, Barbara Schmalfeldt, Volkmar Müller, et al. "MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer." Pathology - Research and Practice 224 (August 2021): 153533. http://dx.doi.org/10.1016/j.prp.2021.153533.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Presl, Jiří, Tomáš Vaněček, Michael Michal, et al. "Molecular classification of endometrial cancers translated into practice." Česká gynekologie 86, no. 4 (2021): 258–62. http://dx.doi.org/10.48095/cccg2021258.

Full text

Abstract:

Summary: Objective: The main objective of the article is to clearly inform healthcare professionals about the newly implemented molecular classification of endometrial cancer into practice. Methods: Summary of current knowledge, recommendations and new procedures relating to molecular genetic examination of the tissues of patients with endometrial carcinoma. Results: Endometrial cancer is currently diagnosed on the base of histopathological morphology. According to the classical Bokhman division, we distinguish between two relatively wide groups of tumors which are different in pathogenesis: t

APA, Harvard, Vancouver, ISO, and other styles

42

Falcon Gonzalez, Alejandro, Luis G. Paz-Ares, Gregory Michael Cote, et al. "Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced endometrial carcinoma." Journal of Clinical Oncology 39, no. 15_suppl (2021): 5586. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.5586.

Full text

Abstract:

5586 Background: LUR is a new agent that exerts antitumor activity through inhibition of trans-activated transcription and modulation of tumor microenvironment. Preclinical synergism/additivity in combination with IRI has been reported, thus prompting the conduct of this trial. This synergism had been evaluated and recently reported in patients with Small Cell Lung Cancer, with encouraging results (Ponce et al. WCLC, 2020). Methods: Phase I trial to evaluate escalating doses of LUR on Day (D) 1 plus a fixed dose of IRI 75 mg/m2 on D1 and D8 every 3 weeks (q3w) in pts with advanced solid tumors

APA, Harvard, Vancouver, ISO, and other styles

43

Anchezar, J. P., A. Soderini, and J. E. Sardi. "PRESERVATION OF FERTILITY IN YOUNG WOMEN WITH ENDOMETROID ENDOMETRIAL CANCER (EEC) STAGE I. LONG TERM FOLLOW UP USING PRIMARY HORMONAL TREATMENT." International Journal of Gynecologic Cancer 13, Suppl 1 (2003): 75.3–75. http://dx.doi.org/10.1136/ijgc-00009577-200303001-00275.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Bhattacharjee, Rumi, Nitin P. Dhungat, and Vishal Sheth. "Comparative study between laparoscopic hysterectomy and abdominal hysterectomy for the treatment of early stage endometrial cancer." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 9, no. 11 (2020): 4526. http://dx.doi.org/10.18203/2320-1770.ijrcog20204804.

Full text

Abstract:

Background: Aim was to study the feasibility of total laparoscopic pan hysterectomy in patients with early stage endometrial cancer.Methods: Retrospective and prospective study of 100 patients with clinical early stage endometrial cancer was done in Bombay Hospital & Research Center over 3 years. 44 patients underwent total laparoscopic hysterectomy while 56 patients underwent abdominal pain hysterectomy. Pelvic lymphadenectomy was performed in patients with myometrium invasion greater than 50%, size of tumor >2 cm, non-endometroid pathology, Grade 3.Results: The mean operating time was

APA, Harvard, Vancouver, ISO, and other styles

45

Van Dam, P., H. Sonnemans, P. J. Van Dam, D. Smet, L. Verkinderen, and L. Y. Dirix. "Sentinel node detection in a patient with recurrent endometrial cancer initially treated by hysterectomy and radiotherapy." International Journal of Gynecologic Cancer 14, no. 4 (2004): 673–76. http://dx.doi.org/10.1136/ijgc-00009577-200407000-00016.

Full text

Abstract:

This is the first article reporting sentinel node identification in a patient with endometrial cancer recurring in the vagina. A 79-year-old woman presented with a midvaginal recurrence of a stage IB, grade II endometroid carcinoma that had been treated 3 years earlier by a total abdominal hysterectomy, bilateral salpingoophorectomy, and pelvic lymph node sampling, followed by adjuvant brachytherapy to the vaginal vault. A staging examination under anesthetic was performed. Preoperatively, 60-MBq technetium-labeled nannocolloid was injected in the mucosa at 3, 6, 9, and 12 o'clock just adjacen

APA, Harvard, Vancouver, ISO, and other styles

46

Gemer, O., M. Gdalevich, M. Voldarsky, et al. "Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: Results of a multicenter study." European Journal of Surgical Oncology (EJSO) 35, no. 8 (2009): 865–69. http://dx.doi.org/10.1016/j.ejso.2008.10.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Richter, Camden, David Mayhew, Jonathan P. Rennhack, et al. "Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer." International Journal of Molecular Sciences 21, no. 22 (2020): 8690. http://dx.doi.org/10.3390/ijms21228690.

Full text

Abstract:

Sarcomere and cytoskeleton genes, or actomyosin genes, regulate cell biology including mechanical stress, cell motility, and cell division. While actomyosin genes are recurrently dysregulated in cancers, their oncogenic roles have not been examined in a lineage-specific fashion. In this report, we investigated dysregulation of nine sarcomeric and cytoskeletal genes across 20 cancer lineages. We found that uterine cancers harbored the highest frequencies of amplification and overexpression of the gamma actin gene, ACTG1. Each of the four subtypes of uterine cancers, mixed endometrial carcinomas

APA, Harvard, Vancouver, ISO, and other styles

48

Subedi, Kirtipal, Meeta Singh, and Neebha Ojha. "Histopathological Pattern of Gynecological Malignancy at Tribhuvan University Teaching Hospital, Nepal." Nepal Journal of Obstetrics and Gynaecology 12, no. 2 (2018): 44–47. http://dx.doi.org/10.3126/njog.v12i2.19952.

Full text

Abstract:

Aims: This study aims to find out histopathological diagnosis and stage at presentation during the diagnosis of female genital tumors.Methodology: This is hospital based prospective observational study of histopathologically confirmed gynecological malignancies conducted in the Department of Obstetrics and Gynecology, TUTH, Maharajgunj, Kathmandu for one year from 2014 to 2015Results: Among 102 cases enrolled in the study, the most common gynecological malignancy was of ovary (48%) followed by cervix (31%), endometrium (11%), vulval (6%), gestational trophoblastic neoplasia (3%) and fallopian

APA, Harvard, Vancouver, ISO, and other styles

49

Yee, Francis Zheng Yi, Grace Hwei Ching Tan, Claramae Shulyn Chia, Khee Chee Soo, and Melissa Ching Ching Teo. "Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy." Pleura and Peritoneum 2, no. 3 (2017): 129–36. http://dx.doi.org/10.1515/pp-2017-0017.

Full text

Abstract:

AbstractBackgroundCytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed treatment for selected patients with peritoneal metastases (PM) arising from appendiceal, colorectal, epithelial ovarian, primary peritoneal and gastric cancers. However, the results of CRS with HIPEC remain unclear in PM from other tumor histologies.MethodsWe report a series of 10 patients who underwent CRS and HIPEC between 2006 and 2015, for PM arising from uncommon tumor origins.ResultsTen patients with PM from uncommon tumor origins underwent CRS and HIPEC. Median age was 46.5

APA, Harvard, Vancouver, ISO, and other styles

50

Shaikh, Naseer Ahmed, Farzana Memon, and Rukhsana Parveen Samro. "TUMOR MARKERS." Professional Medical Journal 21, no. 04 (2018): 621–27. http://dx.doi.org/10.29309/tpmj/2014.21.04.2290.

Full text

Abstract:

Object: Analysis of serum tumor markers CA-125, CEA, AFP, & ß-HCG in patientswith ovarian malignant tumors and correlation of their serum levels with histological types. StudyDesign: Institution based descriptive and prospective study. Place & Duration: Department ofPathology, Liaquat University of Medical & Health Sciences, Jamshoro from January 2009 toJune 2011. Material & Methods: One hundred cases, diagnosed as ovarian malignant tumor onH&E staining were selected for study & measurement of serum CA-125, CEA, AFP, & ß-HCGpreoperatively and postoperatively in each

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!